In clinical trials, Mounjaro has shown HbA1c reductions of up to 2.5%, compared to roughly 1.5% with Ozempic
Although the study has low power due to the limited number of participants involved, it opens the door for further research and development of biomarkers for endometriosis
At Milestone Treatment Center, our board-certified addiction physicians evaluate each client individually to determine if off-label GLP-1 protocol is a safe, appropriate option
This should include further mechanistic studies (e.g., experimental medicine trials) that can support the interpretation of findings from clinical trials
Our guide to preventing muscle loss on GLP-1 medications is a great place to start
Research shows it may be effective for several chronic diseases, including diabetes, cardiovascular disorders and inflammatory diseases